"HIV Core Protein p24" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.
| Descriptor ID |
D016655
|
| MeSH Number(s) |
D12.776.964.775.350.362.500 D12.776.964.775.562.750.500 D12.776.964.970.600.850.350.362.500 D23.050.327.520.300
|
| Concept/Terms |
HIV Core Protein p24- HIV Core Protein p24
- HIV gag Gene Product p24
- HIV Major Core Protein p24
- p24(HIV)
- HIV Protein p24
- p24, HIV Protein
- HTLV-III p24
- HTLV III p24
- p24, HTLV-III
- p24 protein, Human Immunodeficiency Virus
- gag Protein p24, HIV
- HIV p24 Antigen
- p24 Antigen, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Core Protein p24".
Below are MeSH descriptors whose meaning is more specific than "HIV Core Protein p24".
This graph shows the total number of publications written about "HIV Core Protein p24" by people in this website by year, and whether "HIV Core Protein p24" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Core Protein p24" by people in Profiles.
-
Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments. Ann Emerg Med. 2018 07; 72(1):29-40.e2.
-
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 2008 Jul 11; 4(7):e1000101.
-
Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007 Dec 05; 369(1):55-68.
-
Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing. Antimicrob Agents Chemother. 2007 Oct; 51(10):3554-61.
-
Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr. 2007 May 01; 45(1):9-19.
-
HIV infection of mononuclear cells is calcium-dependent. Virus Res. 2006 Dec; 122(1-2):183-8.
-
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J Clin Microbiol. 2005 Dec; 43(12):5950-6.
-
Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus load. AIDS Res Hum Retroviruses. 2005 Nov; 21(11):945-8.
-
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS. 2004 Mar 05; 18(4):605-13.
-
CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology. 2003 Jan; 108(1):3-9.